Clinical Trial Update: Renal Denervation in Refractory Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating renal denervation for resistant hypertension was terminated. The update provides no reported efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Resistant Hypertension

Snippet

Sponsor: Charles University, Czech Republic | Conditions: Hypertension, Resistant to Conventional Therapy | Phase 3 | Status: TERMINATED